Attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder (ADHD) is a developmental disorder.
Adhd Press Articles
Business Wire - Young Children Exposed to Anesthesia Multiple Times Show Elevated Rates of ADHD
February 2, 2012 --
ROCHESTER, Minn. -- Mayo Clinic researchers have found that multiple exposures to Published on Saturday 4th of February 2012 01:10:21 PM
Business Wire - Research and Markets: Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2012
January 24, 2012 --
DUBLIN -- Research and Markets( Published on Saturday 4th of February 2012 01:10:21 PM
Business Wire - 42 Percent of Online Consumers Think Pharma Companies Should be Involved in Online Health Communities – ADD/ADHD and Bipolar Disorder Caregivers Top Groups to Agree
January 17, 2012 -- ePharma Consumerî Study Reveals New Trends around How Consumers Interact with Pharma, Including Customer Service Options, Patient Education,...
Published on Saturday 4th of February 2012 01:10:21 PM
Evening Chronicle (Newcastle, England) - A DOUBLE dose of disadvantage […]
January 9, 2012 --
A DOUBLE dose of disadvantage at the start of life can dramatically multiply a child's chances of being afflicted by ADHD, a study has...
Published on Saturday 4th of February 2012 01:10:21 PM
Business Wire - Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline in ADHD
January 6, 2012 -- Proceeds from the $42M will be used to prepare for the commercial launch of its two lead product candidates in epilepsy and to further the...
Published on Saturday 4th of February 2012 01:10:21 PM
Townsend Letter - Food allergy, ADHD, and the reliability of IgG blood tests
January 1, 2012 --
One hundred children (aged 4-8 years) with attention deficit/hyperactivity disorder (ADHD) were randomly assigned to consume an elimination...
Published on Saturday 4th of February 2012 01:10:21 PM
PR Newswire - New Gene Study of ADHD Points to Defects in Brain Signaling Pathways
December 1, 2011 --
--Children's Hospital of Philadelphia Research Suggests that Interventions at the Glutamate Transmission Level Might Treat Disorder--
...
Published on Saturday 4th of February 2012 01:10:21 PM
Business Wire - Targacept Announces Initiation of Two Phase 2 Studies of TC-5619
December 1, 2011 --
WINSTON-SALEM, N.C. -- Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR...
Published on Saturday 4th of February 2012 01:10:21 PM
Business Wire - Euthymics Bioscience, Inc. Presents Data That Support Advancing EB-1020 into Clinical Trials for Adult ADHD
December 1, 2011 -- Euthymics presented preclinical data demonstrating that EB-1020, a next-generation product candidate for adult ADHD, may be effective for treating...
Published on Saturday 4th of February 2012 01:10:21 PM
Market Wire - Theravance Announces Initiation of Phase 2 Study With Its MARIN Compound, TD-9855, for the Treatment of ADHD
December 1, 2011 --
Theravance, Inc. (NASDAQ: THRX) announced today the initiation of an Attention-Deficit/Hyperactivity Disorder (ADHD) Phase 2 study with...
Published on Saturday 4th of February 2012 01:10:21 PM
Share this!